At the same time, higher CK18 serum levels have been found in NAFLD participants than in other chronic liver patients, with a positive association between the levels of this protein and the stage of liver fibrosis [35,36]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.